Lincoln Pharmaceuticals Limited (LINCOLN) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Lincoln Pharmaceuticals Limited stock ₹579, price ₹521, upside +11.2%, quality 59 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Lincoln Pharmaceuticals Limited
LINCOLN · NSESolid company and rising price, but only slightly cheap (10% below fair value): meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹259.93 – ₹947.93 · fair‑value band ₹376.28 – ₹862.04 · the ₹520.50 price screens below the ₹578.79 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Lincoln Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India.
Show moreShow less
The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics.
It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
Stock analysis
Lincoln Pharmaceuticals Limited (LINCOLN) currently trades at ₹520.50, while our model-based Fair Value estimate is ₹578.79, implying the stock looks roughly 10% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹768.72 per share, and 15 of the 26 models we run sit above the ₹520.50 price.
Bear case: the Asset-Based group reads lowest at ₹224.81, and 11 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹376.28 (bear) to ₹862.04 (bull), the price of ₹520.50 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Lincoln Pharmaceuticals Limited reported revenue of ₹6.7B in FY2026 versus ₹4.7B in FY2022, a compound +9.4%/yr. Reported net income was ₹879M in FY2026, compounding +6.1%/yr from FY2022.
Key figures
Market cap ₹10.4B (≈ $111M) Micro · P/E ratio 10.8 · P/S ratio 1.44 · EPS (TTM) ₹48.38 · Dividend yield 0.3% · Net margin 13.4% · Return on equity 12.7% · Return on assets (EBIT) 15.3% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 55 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −28% fair-value upside, at 11%, LINCOLN screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch LINCOLN, get fair value alerts →
Compare Lincoln Pharmaceuticals Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs LINCOLN |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.66 | ¥53.04 | +11% | vs LINCOLN |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,870 | ₹1,983 | +6% | vs LINCOLN |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs LINCOLN |
| Merck KGaA MRK | €150.75 | €108.83 | −28% | vs LINCOLN |
| Galderma Group GALD | CHF 187.15 | CHF 112.46 | −40% | vs LINCOLN |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs LINCOLN |
| Sandoz Group SDZ | CHF 83.00 | CHF 40.54 | −51% | vs LINCOLN |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs LINCOLN |
| Divi's Laboratories Limited DIVISLAB | ₹11,150 | ₹1,567 | −86% | vs LINCOLN |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Lincoln Pharmaceuticals Limited (LINCOLN) overvalued or undervalued?
What is the fair value of LINCOLN?
What is the quality score of LINCOLN?
What is the price target for Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the Lincoln Pharmaceuticals Limited stock forecast for 2026?
What is the revenue of Lincoln Pharmaceuticals Limited (LINCOLN)?
Does Lincoln Pharmaceuticals Limited pay a dividend?
How much is the dividend of Lincoln Pharmaceuticals Limited (LINCOLN) and when is the ex-dividend date?
What growth is priced into Lincoln Pharmaceuticals Limited (LINCOLN)?
What discount rate (WACC) does the fair value of LINCOLN use?
What is a reverse DCF?
How much growth has Lincoln Pharmaceuticals Limited (LINCOLN) delivered so far?
How fast is the sector of Lincoln Pharmaceuticals Limited (LINCOLN) growing?
What is the free cash flow yield of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the intrinsic value of Lincoln Pharmaceuticals Limited (LINCOLN)?
Is Lincoln Pharmaceuticals Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LINCOLN?
How much is Lincoln Pharmaceuticals Limited worth?
What do the bullish and bearish scenarios say about LINCOLN?
What is the P/E ratio of LINCOLN?
How solid is the balance sheet of Lincoln Pharmaceuticals Limited (LINCOLN)?
How far is LINCOLN from its 52-week high?
Which stocks are comparable to Lincoln Pharmaceuticals Limited?
Is Lincoln Pharmaceuticals Limited stock attractive at the current price?
How is the fair value of LINCOLN calculated?
Is it still worth investing in stocks now?
What is the share price of Lincoln Pharmaceuticals Limited (LINCOLN)?
What should I pay attention to with Lincoln Pharmaceuticals Limited right now?
Where does the earnings growth of Lincoln Pharmaceuticals Limited (LINCOLN) come from?
Key figures of Lincoln Pharmaceuticals Limited
How large is the market capitalisation of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the P/S ratio of Lincoln Pharmaceuticals Limited (LINCOLN)?
What are the earnings per share of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the dividend yield of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the net margin of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the return on equity of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the EBIT return on assets of Lincoln Pharmaceuticals Limited (LINCOLN)?
What is the operating margin of Lincoln Pharmaceuticals Limited (LINCOLN)?
How fast is revenue growing at Lincoln Pharmaceuticals Limited (LINCOLN)?
How fast are earnings growing at Lincoln Pharmaceuticals Limited (LINCOLN)?
How much net cash does Lincoln Pharmaceuticals Limited (LINCOLN) hold?
Watch Lincoln Pharmaceuticals Limited in the live analysis
One click puts Lincoln Pharmaceuticals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.